Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Medical - Devices

Healthcare
$17.05 +1.53%

+$0.24 today

Market cap
$1.19B
Beta
1.57
P/E (TTM)
-11.3
EPS (TTM)
-$1.38
52W Low $9.98High $29.65

Volume 2.35M

Average 2.43M

TNDM Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

Tandem Diabetes Care, Inc.NASDAQ: TNDM

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow turns negative

Q1 FY2026 investing cash flow was -$195.45M, compared with $9.19M a year earlier. Trailing-twelve-month investing cash flow was -$131.76M. Over 3 fiscal years it compounded at +30.0% a year.

Context

  • Investing cash flow amounted to 7.2% of revenue in FY2025, up 4.7 pp from a year earlier.
  • Investing cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly investing cash flow holds near -$195.45M or moves back toward the trailing-twelve-month quarterly average of -$32.94M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$195.45M+1205.1% QoQ
Last fiscal yearDec 2025
$72.88M+410.3% YoY
LTMMar 2026
-$131.76M+1326.0% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2227.7%——
1 year+410.3%——
3-year CAGR+30.0%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
72.88M USD
Year-over-year change
+410.3%

Investing Cash Flow vs competitors

How TNDM compares with its peers on the latest reported figures

  • TNDM's LTM Mar 2026 investing cash flow of $131.76M is the 5th largest of the 8 companies compared; the peer median is $10.1M.
  • Its year-over-year change of +1326.0% is the highest of 7, against a peer median of +101.4%.
  • Investing cash flow amounts to 12.8% of revenue for TNDM, versus a peer median of 17.7%.
TNDM Competitors Peer median
Investing Cash Flow for TNDM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$530.7M +1034.3%—10.7%
MNKDMannKind CorporationLTM Mar 2026$292.04M +591.2%—80.9%
PODDInsulet CorporationLTM Jun 2026$248.9M +82.7%+5.2%8.2%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$211M —+9.0%6.5%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$131.76M +1326.0%+30.0%12.8%
BBNXBeta Bionics, Inc.LTM Mar 2026$38.16M +120.1%+496.0%34.6%
SENSSenseonics Holdings, Inc.LTM Mar 2026$10.1M -43.5%—24.8%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$109K -90.6%+115.1%—
MMEDVMiniMed Group, Inc.—— ———
Peer median (excluding TNDM) $10.1M+101.4%+62.0%17.7%

Competitors are the stored peer set for TNDM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income15.57M(94.59M)(222.61M)(96.03M)(204.71M)
Depreciation & Amortization13.85M14.33M15.72M16.61M13.84M
Deferred Income Tax00000
Stock-Based Compensation60.75M84.92M88.08M101.38M92.38M
Change in Working Capital14.37M(4.65M)(17.69M)(11.78M)(23.04M)
Accounts Receivables(30.98M)(7.83M)4.28M(20.8M)(56.81M)
Inventory(4.95M)(42.45M)(46.05M)5.81M24.82M
Accounts Payables10.28M24.49M(4.86M)(2.39M)2.23M
Other Working Capital40.03M21.14M28.96M5.6M6.73M
Other Non-Cash Items6.82M50.46M104.7M14.04M111.81M
Operating Cash Flow111.36M50.46M(31.81M)24.23M(9.72M)
Capital Expenditures(23.51M)(34.1M)(26.8M)(19.23M)(19.95M)
Acquisitions (Net)0(25.72M)(69.5M)00
Purchases of Investments(733.39M)(467.65M)(535.66M)(264.31M)(85.66M)
Sales of Investments570.02M569.49M546.22M306.46M257.07M
Other Investing Activities(9.33M)(8.86M)0(46.4M)(78.59M)
Investing Cash Flow(186.88M)33.17M(85.74M)(23.48M)72.88M
Debt Repayment00044.91M(40.76M)
Common Stock Issued017.55M0(6.73M)(2.61M)
Common Stock Repurchased000(30M)0
Dividends Paid00000
Other Financing Activities51.93M(675K)4.11M183K0
Financing Cash Flow51.93M16.88M4.11M8.37M(43.37M)
Effect of Forex Changes153K827K(212K)1.26M1.61M
Net Change in Cash(23.43M)101.34M(113.65M)10.37M21.4M
Free Cash Flow87.85M16.37M(58.61M)4.99M(29.67M)

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.